Assessment of Short-term Effect of L-Citrulline on Endothelial Function and Vasodilation in Known CAD Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to determine the efficacy of oral L-Citrulline on endothelial function and vasodilation in patients with coronary artery disease(CAD) by evaluating the brachial artery diameter in the antecubital area by ultrasonography.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Before prescribing the drug or placebo, the patients were evaluated via the ultrasound machine equipped. The brachial artery diameter in the antecubital area was measured by the ultrasound and was recorded. Then blood pressure cuff was attached on the arm and dilated 50mmhg above the systolic pressure and for 5 minutes remained the same level to induce ischemia at distal tissues until the occurrence of compensatory vasodilatation. Then the brachial artery diameter (as an estimation of FMD) was measured and recorded. After 4 minutes of administration of 2 puffs of nitroglycerin spray, the brachial artery diameter (as an estimation of NMD) was measured.
After 15 days treatment with the L-Citrulline or the placebo, the patients underwent the ultrasonography again and the above assessments were done.
Improvement of FMD to NMD ratio (before L-Citrulline prescription) to FMD to NMD ratio (after L-Citrulline prescription) is determined as "improvement of flow mediated dilation to nitroglycerin dependent vasodilation" evaluate.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Drug Arm This group treat with L-Citrulline (3 grams per day) |
Drug: L-Citrulline
This group treat with L-Citrulline (3 grams per day)
|
Placebo Comparator: Placebo Arm this group treat with placebi every day |
Drug: placebo
This group treat with placebo dayley
|
Outcome Measures
Primary Outcome Measures
- improvement of flow mediated dilation to nitroglycerin dependent vasodilation [15 days]
improvement of FMD to NMD ratio (before L-Citrulline prescription) to FMD to NMD ratio (after L-Citrulline prescription)
Eligibility Criteria
Criteria
Inclusion Criteria:
- history of documented CAD; flow mediated dilation to nitroglycerin dependent vasodilation (FMD/NMD)ratio less than 1
Exclusion Criteria:
- no documented CAD; flow mediated dilation to nitroglycerin dependent vasodilation (FMD/NMD)ratio equal /more than 1
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Shahid Modaress Hospital , Tehran, Iran | Tehran | Iran, Islamic Republic of |
Sponsors and Collaborators
- Shahid Beheshti University of Medical Sciences
Investigators
- Study Director: Morteza Safi, MD, Cardiovascular Research Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CVRC101